Mgr. Lucie Kubínová
Analyst, Institute of Biostatistics and Analyses
Correspondence Address:
Kamenice 753/5, 625 00 Brno
E‑mail: |
---|
Inactive employment status
Total number of publications: 43
2022
-
Identification of patients at high risk of secondary extramedullary multiple myeloma development
British journal of haematology, year: 2022, volume: 196, edition: 4, DOI
-
Myocardial injury in stress echocardiography: Comparison of dobutamine, dipyridamole and dynamic stressors-single center study
Echocardiography - A Journal of Cardiovascular Ultrasound and Allied Techniques, year: 2022, volume: 39, edition: 9, DOI
2021
-
Bortezomib-based therapy for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation: Czech Registry Data
European Journal of Haematology, year: 2021, volume: 107, edition: 4, DOI
-
Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis
haematologica, year: 2021, volume: 106, edition: 2, DOI
-
LncRNAs LY86-AS1 and VIM-AS1 Distinguish Plasma Cell Leukemia Patients from Multiple Myeloma Patients
Biomedicines, year: 2021, volume: 9, edition: 11, DOI
-
Necessity of flow cytometry assessment of circulating plasma cells and its connection with clinical characteristics of primary and secondary plasma cell leukaemia
British journal of haematology, year: 2021, volume: 195, edition: 1, DOI
-
Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice
BMC Cancer, year: 2021, volume: 21, edition: 1, DOI
-
Urine immunofixation negativity is not necessary for complete response in intact immunoglobulin multiple myeloma: Retrospective real-world confirmation
International Journal of Laboratory Hematology, year: 2021, volume: 43, edition: 5, DOI
2020
-
Bortezomib retreatment is effective in relapsed multiple myeloma patients - real-life clinical practice data
Neoplasma, year: 2020, volume: 67, edition: 1, DOI
-
Diagnostic relevance of 18F-FDG PET/CT in newly diagnosed patients with monoclonal gammopathy of undetermined significance (MGUS): Single-center experience
Neoplasma, year: 2020, volume: 67, edition: 4, DOI